OUR INVESTMENT IN LANGAWARE – THE MACHINE LEARNING AND LANGUAGE BIOMARKERS SOLUTION FOR NEURODEGENERATIVE PATHOLOGIES DETECTION
- Posted by Metavallon VC Team
- On July 22, 2020
- No tags found
We are excited to announce our latest Seed investment into healthtech startup LangAware, which provides a solution of early cognitive assessment to prevent Alzheimer’s and related Dementias. Founded by Vassiliki Rentoumi, associate researcher in the field of Natural Language Processing and Computational Linguistics at SKEL of NCSR “Demokritos”, LangAware employs Artificial Intelligence to predict neurodegenerative […]
Read More



